Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Epigenetics Market?

In recent times, the epigenetics market has witnessed considerable growth. Projected growth estimates suggest a rise from $10.65 billion in 2024 to $12.83 billion in 2025, implying a compound annual growth rate (CAGR) of 20.4%. The historic period’s growth is credited to factors such as enhanced research funding, an escalation in chronic disease cases, the advent of personalized medicine, innovation in cancer research, and an aging demographic.

What Growth Rate Is Forecasted for the Epigenetics Market by 2029?

Rapid expansion is anticipated for the epigenetics market in the coming years, with predictions pointing to a surge to $29.08 billion by 2029, marking a compound annual growth rate (CAGR) of 22.7%. This projected growth in the forecast period can be credited to factors such as the development of epigenetic drugs, the role of epigenetics in environmental health and precision agriculture, regulatory backing, improved patient awareness, and advocacy efforts. Noteworthy trends anticipated throughout the forecast period encompass epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, research in aging and longevity, and interactions between the microbiome and epigenome.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Which Key Companies Are Shaping the Future of the Epigenetics Market?

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Which Factors Are Driving Demand in the Epigenetics Industry?

The escalating occurrence of cancer and various other diseases is a significant contributor to the expansion of the epigenetics market. As the frequency of diseases rises, so does the need for epigenetics. Take for instance May 2024 data from the National Cancer Institute (NCI), a Government agency in the US, there were nearly 20 million new cancer cases reported in 2022, with approximate death count reaching up to 9.7 million due to the disease. It is anticipated that by 2040, the yearly number of new cancer diagnoses will expand to an alarming 29.9 million, whilst deaths due to this disease might rise to 15.3 million. Moreover, the Centers for Disease Control and Prevention (CDC) reports roughly 659,000 people in America die annually due to heart disease. The increasing occurrence of cancer and other diseases mandates tests and knowledge about genetic modifications, which will inevitably escalate the utility and need for epigenetics. Therefore, the growing occurrence of cancer and other diseases is a key driving factor for the expansion of the epigenetics market in upcoming years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

How Is the Epigenetics Market Segmented by Several Divisions?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

What are the Emerging Market Trends Driving the Growth of the Epigenetics Industry?

Leading firms in the epigenetics market are concentrating on the invention of cutting-edge solutions, such as DNA sequencing techniques, in order to upgrade precision medicine and enrich our understanding and results in disease treatment. DNA sequencing techniques identify the sequence of nucleotides in a DNA molecule, which is critical for thorough genetic analysis. Such data is indispensable in detecting genetic changes associated with diseases and promoting personalized medicine. For instance, in March 2023, Illumina Inc., a biotech company based in the US, unveiled the Illumina Complete Long Read Technology. This technology allows for both long-read and short-read sequencing on one device, markedly increasing versatility in genomic research. With lowered DNA input requirements and a smooth workflow, it renders the library preparation process simpler, making it manageable for difficult samples. The technology provides very accurate variant calling, yielding trustworthy data crucial for exhaustive genomic analysis.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Regions Are Driving Growth in the Epigenetics Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

This Report Delivers Insight On:

1. How big is the epigenetics market, and how is it changing globally?

2. Who are the major companies in the epigenetics market, and how are they performing?

3. What are the key opportunities and risks in the epigenetics market right now?

4. Which products or customer segments are growing the most in the epigenetics market?

5. What factors are helping or slowing down the growth of the epigenetics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model